Tucson, ARIZONA4 Active Studies

Melanoma Clinical Trials in Tucson, ARIZONA

Find 4 actively recruiting melanoma clinical trials in Tucson, ARIZONA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,657
Enrolling

Recruiting Melanoma Studies in Tucson

RecruitingTucson, ARIZONANCT06112314

IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)

This is a phase 3, randomized, controlled study of brenetafusp (IMC-F106C) plus nivolumab compared to standard nivolumab regimens in HLA-A\*02:01-positive participants with previously untreated advanc...

680 participants
Immunocore Ltd
View Study Details
RecruitingTucson, ARIZONANCT06246916

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

This study is researching an experimental drug called fianlimab (also known as REGN3767), combined with another medication called cemiplimab (also known as REGN2810), called "study drugs". The study i...

560 participants
Regeneron Pharmaceuticals
View Study Details
RecruitingTucson, ARIZONANCT03897881

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

The purpose of this study is to assess whether postoperative adjuvant therapy with mRNA-4157 and pembrolizumab improves recurrence free survival (RFS) compared to pembrolizumab alone in participants w...

267 participants
ModernaTX, Inc.
View Study Details
RecruitingTucson, ARIZONANCT04462406

Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial

This phase II trial investigates how well biomarkers on PET/CT imaging drive early discontinuation of anti-PD-1 therapy in patients with stage IIIB-IV melanoma that cannot be removed by surgery (unres...

150 participants
ECOG-ACRIN Cancer Research Group
View Study Details

About Melanoma Clinical Trials in Tucson

Melanoma is the most serious type of skin cancer, developing from the pigment-producing cells known as melanocytes. While less common than other skin cancers, melanoma is more likely to spread. Immunotherapy and targeted therapy have revolutionized melanoma treatment.

There are currently 4 melanoma clinical trials recruiting participants in Tucson, ARIZONA. These studies are seeking a combined 1,657 participants. Research is being sponsored by Immunocore Ltd, Regeneron Pharmaceuticals, ModernaTX, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Melanoma Clinical Trials in Tucson — FAQ

Are there melanoma clinical trials in Tucson?

Yes, there are 4 melanoma clinical trials currently recruiting in Tucson, ARIZONA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tucson?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.

Are clinical trials in Tucson free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.

What melanoma treatments are being tested?

The 4 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for melanoma.

Data updated March 2, 2026 from ClinicalTrials.gov